Dan Rock is the Chief Scientific Officer at Cartography Biosciences; he serves as the lead of scientific operations, aligning future scientific strategies with the company’s mission and vision. Prior to Cartography, he was the Vice President of Pharmacokinetics, Dynamics, Metabolism and Bioanalytics at Merck where he was responsible for the design, optimization and translation of novel biologics and small molecules into the clinic. Dan completed his PhD studying physical chemistry at Washington State University. Outside of work, Dan spends time traveling with his family and bicycling.
Recent Posts
- Cartography Announces Appointment of Troy Wilson, Ph.D., J.D., to its Board of Directors
- Cartography Announces Strategic Collaboration with Gilead to Develop Oncology Therapies Against Novel Targets and Target Pairs
- Cartography Biosciences Expands Leadership Team with Appointment of Dan Rock, Ph.D., as Chief Scientific Officer to Advance Novel Oncology Programs into Clinic
- Cartography Biosciences and Nested Therapeutics: Diamonds in the rough
- Cartography Biosciences Expands Scientific Advisory Board with Leading Antibody and Bi-specific Experts
Recent Comments
No comments to show.